These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28266198)

  • 1. "Silent" β-thalassemia mutation (promoter nt-101 C > T) with increased hemoglobin A
    Aslan D
    Turk J Pediatr; 2016; 58(3):305-308. PubMed ID: 28266198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal delta globin gene sequence in carrier of the silent-101 (C-T) beta-thalassemia mutation with normal HbA2 level.
    Ristaldi MS; Casula S; Porcu S; Cao A
    Am J Hematol; 2001 May; 67(1):58. PubMed ID: 11279661
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel Mediterranean "delta beta-thalassemia" determinant containing the delta (+) 27 and beta (0) 39 point mutations in cis.
    Oggiano L; Guiso L; Frogheri L; Loudianos G; Pistidda P; Rimini E; Pirastu M; Cao A; Longinotti M
    Am J Hematol; 1994 Jan; 45(1):81-4. PubMed ID: 7504402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia.
    Gonzalez-Redondo JM; Stoming TA; Kutlar A; Kutlar F; Lanclos KD; Howard EF; Fei YJ; Aksoy M; Altay C; Gurgey A
    Blood; 1989 May; 73(6):1705-11. PubMed ID: 2713503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectrum of delta-globin gene in the Portuguese population.
    Morgado A; Picanço I; Gomes S; Miranda A; Coucelo M; Seuanes F; Seixas MT; Romão L; Faustino P
    Eur J Haematol; 2007 Nov; 79(5):422-8. PubMed ID: 17916081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-thalassemia intermedia due to compound heterozygosity for two beta-globin gene promoter mutations, including a novel TATA box deletion.
    Basran RK; Reiss UM; Luo HY; Ware RE; Chui DH
    Pediatr Blood Cancer; 2008 Feb; 50(2):363-6. PubMed ID: 16732578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of -73(A-->T) in the CCAAT box of the beta-globin gene identified in a patient with the mild beta-thalassemia intermedia.
    Chen XW; Mo QH; Li Q; Zeng R; Xu XM
    Ann Hematol; 2007 Sep; 86(9):653-7. PubMed ID: 17516066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype of subjects with borderline hemoglobin A2 levels: implication for beta-thalassemia carrier screening.
    Galanello R; Barella S; Ideo A; Gasperini D; Rosatelli C; Paderi L; Paglietti E; Sollaino C; Perseu L; Loi D
    Am J Hematol; 1994 Jun; 46(2):79-81. PubMed ID: 8172199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular, haematological and clinical studies of the -101 C --> T substitution of the beta-globin gene promoter in 25 beta-thalassaemia intermedia patients and 45 heterozygotes.
    Maragoudaki E; Kanavakis E; Traeger-Synodinos J; Vrettou C; Tzetis M; Metaxotou-Mavrommati A; Kattamis C
    Br J Haematol; 1999 Dec; 107(4):699-706. PubMed ID: 10606872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-thalassemia intermedia with exceptionally high hemoglobin A2: relationship to mutations in the beta-gene promoter.
    Coleman MB; Adams JG; Plonczynski MW; Harrell AH; Walker AM; Fairbanks V; Steinberg MH
    Am J Med Sci; 1992 Aug; 304(2):73-8. PubMed ID: 1380206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-thalassemia intermedia associated with homozygosity for the -87 (C-->T) mutation in a Turkish family.
    Gümrük F; Mergen H; Oner R; Ozcebe O; Sayinalp N; Oner C; Gürgey A; Altay C
    Hemoglobin; 2000 Feb; 24(1):23-9. PubMed ID: 10722112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-heredity of silent CAP + 1570 T>C (HBB:c*96T>C) defect and severe β-thal mutation: a cause of mild β-thalassemia intermedia.
    Vinciguerra M; Passarello C; Cassarà F; Leto F; Cannata M; Calvaruso G; Di Maggio R; Renda D; Maggio A; Giambona A
    Int J Lab Hematol; 2016 Feb; 38(1):17-26. PubMed ID: 26418075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new high A2-beta-thalassemia due to a 468 bp deletion (-475 to -8) in the beta-globin gene promoter of the intact beta-globin structural gene.
    Kueviakoe I; Gerard N; Krishnamoorthy R; Pereira S; Elion J; Ducrocq R
    Hemoglobin; 2004 Feb; 28(1):69-72. PubMed ID: 15008268
    [No Abstract]   [Full Text] [Related]  

  • 15. Levels of Hb A2 in heterozygotes and homozygotes for beta-thalassemia mutations: influence of mutations in the CACCC and ATAAA motifs of the beta-globin gene promoter.
    Huisman TH
    Acta Haematol; 1997; 98(4):187-94. PubMed ID: 9401495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large cohort of β(+)-thalassemia in Thailand: molecular, hematological and diagnostic considerations.
    Yamsri S; Singha K; Prajantasen T; Taweenan W; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Blood Cells Mol Dis; 2015 Feb; 54(2):164-9. PubMed ID: 25471338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of turkish beta-thalassemia heterozygotes with normal Hb A2 levels.
    Oner R; Birben E; Acar C; Oner C; Kara A; Gümrük F; Gürgey A; Altay C
    Hemoglobin; 2000 Aug; 24(3):195-201. PubMed ID: 10975439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases.
    Colaco S; Colah R; Ghosh K; Nadkarni A
    Clin Chim Acta; 2012 Oct; 413(19-20):1705-7. PubMed ID: 22659060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-T substitution in the distal CACCC box of the beta-globin gene promoter is a common cause of silent beta thalassaemia in the Italian population.
    Ristaldi MS; Murru S; Loudianos G; Casula L; Porcu S; Pigheddu D; Fanni B; Sciarratta GV; Agosti S; Parodi MI
    Br J Haematol; 1990 Apr; 74(4):480-6. PubMed ID: 2346726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent thalassemias: genotypes and phenotypes.
    Bianco I; Cappabianca MP; Foglietta E; Lerone M; Deidda G; Morlupi L; Grisanti P; Ponzini D; Rinaldi S; Graziani B
    Haematologica; 1997; 82(3):269-80. PubMed ID: 9234571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.